CUSIP: 14159U301
What is CUSIP 14159U301?
CUSIP 14159U301 identifies CRME - CARDIOME PHARMA CORP - COM NO PAR in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 14159U301:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2018 Q2 | 0 | $0 | -$38,270,580 | 0 | |
| 2018 Q1 | 16,495,792 | $38,270,580 | -$2,458,251 | $2.32 | 18 |
| 2017 Q4 | 17,599,573 | $27,276,386 | -$907,107 | $1.55 | 23 |
| 2017 Q3 | 18,166,978 | $38,734,105 | -$1,016,296 | $2.13 | 26 |
| 2017 Q2 | 18,631,444 | $84,209,221 | +$511,329 | $4.51 | 25 |
| 2017 Q1 | 18,618,678 | $55,999,161 | -$2,573,813 | $3.01 | 29 |
| 2016 Q4 | 19,489,549 | $53,789,000 | -$1,052,490 | $2.76 | 31 |
| 2016 Q3 | 19,782,372 | $62,023,000 | +$24,099,471 | $3.13 | 28 |
| 2016 Q2 | 12,028,960 | $61,629,000 | -$2,717,883 | $5.12 | 26 |
| 2016 Q1 | 12,672,222 | $51,829,000 | -$166,357 | $4.09 | 23 |
| 2015 Q4 | 12,609,240 | $102,259,000 | +$1,568,385 | $8.11 | 28 |
| 2015 Q3 | 12,393,846 | $104,604,000 | +$27,855,926 | $8.44 | 26 |
| 2015 Q2 | 9,088,507 | $85,523,000 | +$16,192,180 | $9.41 | 30 |
| 2015 Q1 | 7,372,213 | $68,281,000 | +$5,388,441 | $9.26 | 30 |
| 2014 Q4 | 6,791,046 | $62,791,000 | +$6,395,478 | $9.25 | 28 |
| 2014 Q3 | 5,795,877 | $51,747,000 | +$4,366,628 | $8.93 | 26 |
| 2014 Q2 | 5,341,110 | $42,001,000 | -$3,763,095 | $7.85 | 29 |
| 2014 Q1 | 5,813,782 | $46,022,000 | +$1,781,294 | $7.91 | 27 |